News
A new analysis shows no clear link between paternal valproate use and harm in offspring, raising questions about the EMA ...
Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND® in Rare Blood Disorders
Avanzanite Bioscience B.V. ("Avanzanite"), a fast-growing commercial-stage specialty pharmaceutical company dedicated to ...
The virus can be fatal in up to 85% of cases, initially causing symptoms such as fever, headaches, pain, vomiting and a sore ...
Alnylam Pharmaceuticals, Inc. , the leading RNA interference (RNAi) therapeutics company, today announced that the European Commission (EC) has granted approval for the treatment of wild-type or ...
Cholesterol API Market Cholesterol API Market Forecast $336.9M in 2025 to $508.4M by 2035 NEW YORK, DE, UNITED STATES, June 9, 2025 /EI ...
In this article, GlobalData examines key reimbursement trends that reflect the current delays to patient access across the ...
The European Medicines Agency has indicated that Novo Nordisk's drugs, Ozempic and Wegovy, may rarely cause a serious eye ...
Nipah is seen by the World Health Organisation as a research priority because of its pandemic potential. The virus is fatal ...
Novo Nordisk's popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition ...
Texas reports no new measles cases for the first time since February, maintaining 742 total cases. Meanwhile, Novo Nordisk's Ozempic is linked to rare serious eye disorders, possibly causing vision ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results